Skip to content

Music in Reducing Distress in Participants with Cancer During Chemotherapy Treatment

Using Music As a Tool for Distress Reduction During Cancer Treatment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03683420
Enrollment
1000
Registered
2018-09-25
Start date
2018-02-14
Completion date
2020-12-31
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caregiver, Malignant Neoplasm

Brief summary

This trial studies how well music works in reducing distress in participants with cancer during chemotherapy treatment. Music in participants receiving cancer treatment such as infusion treatment and caregiver may reduce pain, anxiety, and distress and improve participant's psychological and physiological wellbeing.

Detailed description

PRIMARY OBJECTIVES: I. To test the effect of patients? listening to music on level of distress during cancer treatment. SECONDARY OBJECTIVES: I. To explore the influence of covariates (patients? sociodemographics, musical background, and clinical variables) on the association between patients? listening to music and level of distress during cancer treatment. II. To explore the interdependence of adjustment among patients and their caregivers on the association between. OUTLINE: Participants and caregivers are randomized to 1 of 2 groups. GROUP I: Participants and caregivers listen to music of their choice for up to 60 minutes during infusion session. GROUP II: Participants and caregivers do not listen to music during infusion session and are placed on music waitlist.

Interventions

BEHAVIORALMusic Therapy

The intervention consists of using an iPod to listen to music for up to 60 minutes while patients are receiving chemo infusion. There are no on components to the study.

Sponsors

Barbara Ann Karmanos Cancer Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Able to speak, read, write and understand English * Have sufficient hearing capacity to hear music

Exclusion criteria

* Patients with cognitive or perceptual disturbances will be excluded

Design outcomes

Primary

MeasureTime frameDescription
Changes in pain assessed by Visual Analogue Scale1 hourClinical variables will be summarized by median and range for continuous variables and by count and percentage for categorical variables. The changes between pre- and post-survey will be compared between control and experimental groups using an unpaired t-test. Total scores are reported with the total scores ranging from 0-10; higher scores indicate more pain.
Changes in mood assessed by Positive and Negative Affect Scale1 hourClinical variables will be summarized by median and range for continuous variables and by count and percentage for categorical variables. The changes between pre- and post-survey will be compared between control and experimental groups using an unpaired t-test. There are two subscales: Positive Affect and Negative Affect. Scores for each subscale (10 items each) range from 10 to 50 with higher scores meaning higher levels of affect (either higher positive or higher negative affect).
Changes in distress assessed by Distress Thermometer.1 hourClinical variables will be summarized by median and range for continuous variables and by count and percentage for categorical variables. The changes between pre- and post-survey will be compared between control and experimental groups using an unpaired t-test. Total scores are reported with the total scores ranging from 0-10; higher scores indicate more pain.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026